To test whether FOXH1 promoted HCC progression in vivo, we first orthotopically implanted luciferase-based Vector or FOXH1 HA22T (1X106) into the livers of nude mice and examined tumor growth by using IVIS system. The gene discussed is FOXH1; the disease is neoplasm.